|
|
TAN 23 HM 0057
|
PHESGO 1200-600
|
Alfa, alfa- Trehalose Dihydrate 397 mg/6 mL,L- Methionine 22.4 mg/6 mL,L-Histidine 6.75 mg/6 mL,L-Histidine Hydrochloride Monohydratea 53.7 mg/6 mL,Pertuzumab 1200 mg/15 ml,Polysorbate 20 6.00 mg/6 mL,RHuPH20 -- mg/6 mL,Sucrose 685 mg/6 mL,Trastuzumab 600 mg/15 ml,Water for Injection QS to 15mL ml
|
F. Hoffmann-La Roche Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 23 HM 0058
|
PHESGO 600-600
|
Alfa, alfa- Trehalose Dihydrate 397 mg/6 mL,L- Methionine 22.4 mg/6 mL,L-Histidine 6.75 mg/6 mL,L-Histidine Hydrochloride Monohydratea 53.7 mg/6 mL,Pertuzumab 600 mg/ 10 mL ,Polysorbate 20 6.00 mg/6 mL,RHuPH20 -- mg/6 mL,Sucrose 685 mg/6 mL,Trastuzumab 600 mg/10ml,Water for Injection QS to 15 ml
|
F. Hoffmann-La Roche Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 24 HM 0346
|
Vabysmo 6 mg/0.05 mL solution for injection
|
Acetic Acid - q.s,Faricimab 6 mg/0.05ml,L-Histidine 155 mcg,L-Methionine 52.2 mcg,Polysorbate 20 20 mcg,Sodium Chloride. 73.1 mcg,Sucrose 2.74 mg/6 mL,Water for Injection 1 QS
|
F. Hoffmann-La Roche Ltd
|
Registered/Compliant
|
Details →
|
|
|
TAN 22 HM 0512
|
Tecentriq
|
Atezolizumab 840 mg/14 ml,Glacial Acetic Acid 11.5 mg/6 mL,L histidine 43.4 mg/6 mL,Polysorbate 20 5.6 mg/6 mL,Sucrose 575.1 mg/6 mL,Water for Injection Q.S to 14.0ml q.s
|
F. Hoffmann-La Roche Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 23 HM 0633
|
Xofluza 20 mg
|
Baloxavir Marboxil 20 mg/6 mL,Croscarmellose Sodium 5.5 mg/6 mL,Lactose Monohydrate 77.9 mg/6 mL,Microcrystalline Cellulose 11.4 mg/6 mL,OPADRY WHITE 03A48081 4.8 mg/6 mL,Povidone K-25 5.5 mg/6 mL,Purified Water 1 QS,Sodium Stearyl Fumarate 1.7 mg/6 mL,Talc 0.2 mg/6 mL
|
F. Hoffmann-La Roche Ltd
|
Registered/Compliant
|
Details →
|
|
|
TAN 23 HM 0638
|
Xofluza 40 mg
|
Baloxavir Marboxil 40 mg/6 mL,Croscarmellose Sodium 11 mg/6 mL,Lactose Monohydrate 155.8 mg/6 mL,Microcrystalline Cellulose 22.8 mg/6 mL,OPADRY WHITE 03A48081 7.6 mg/6 mL,Povidone K-25 11 mg/6 mL,Purified Water - -,Sodium Stearyl Fumarate 3.4 mg/6 mL,Talc 0.3 mg/6 mL
|
F. Hoffmann-La Roche Ltd
|
Registered/Compliant
|
Details →
|
|
|
TAN 23 HM 0070
|
OCREVUS
|
Ocrelizumab 300 mg/10ml
|
-
|
Registered/Compliant
|
Details →
|
|
|
TAN 21 HM 0223
|
Perjeta
|
Pertuzumab 420 mg/14 ml
|
Roche Diagnostics GmbH
|
Registered/Compliant
|
Details →
|
|
|
TAN 21 HM 0228
|
Tecentriq
|
Atezolizumab 1200 mg/20 ml
|
F. Hoffmann-La Roche Limited
|
Registered/Compliant
|
Details →
|
|
|
TZ 19 H 0077
|
herceptin SC
|
Trastuzumab 600 mg/5 ml
|
F.HOFFMAN-LA ROCHE LTD
|
Registered/Compliant
|
Details →
|
|
|
TAN 09,014 V03A FLR
|
Avastin
|
Bevacizumab 100 TCID
|
F. Hoffmann-La Roche Ltd
|
Registered/Compliant
|
Details →
|